Get startedLog in
    Picture of Breathe BioMedical logo

    BRTH — Breathe BioMedical Income Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareMicro Cap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Breathe BioMedical, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M
    Source:PROSPECTUSPROSPECTUSPROSPECTUS
    Standards:
    USG
    USG
    USG
    Status:FinalFinalFinal
    Total Revenue000
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Total Operating Expenses5.055.49.17
    Operating Profit-5.05-5.4-9.17
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-3.97-4.46-8.36
    Provision for Income Taxes
    Net Income After Taxes-3.97-4.46-8.36
    Net Income Before Extraordinary Items
    Net Income-3.97-4.46-8.36
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-3.97-4.46-8.36
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-0.364-0.408-0.766
    Dividends per Share